Pediatrics 1 mcqs saqs and laqs from topic one

Asking for Preferences
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
I now have solid content from authoritative pediatric sources. Let me compile comprehensive questions across all three formats covering Pediatrics Topic 1 (Growth, Development, and Newborn Assessment).

Pediatrics 1 — Topic 1: Growth, Development & Newborn Assessment

MCQs (Multiple Choice Questions)


MCQ 1. A newborn infant is assessed at 1 minute of life. The findings are: heart rate 90 bpm, weak irregular respirations, some limb flexion, grimace on stimulation, and blue extremities with a pink body. What is this infant's Apgar score?
  • A) 3
  • B) 4
  • C) 5
  • D) 6
  • E) 7
Answer: C — 5 Scoring: HR <100 = 1, irregular respirations = 1, some flexion = 1, grimace = 1, blue extremities/pink body = 1. Total = 5.

MCQ 2. At what interval(s) is the Apgar score routinely assessed?
  • A) 1 minute only
  • B) 5 minutes only
  • C) 1 and 5 minutes
  • D) 2 and 10 minutes
  • E) Every 5 minutes starting at birth
Answer: C — 1 and 5 minutes If the score remains <7 at 5 minutes, it is repeated at 5-minute intervals up to 20 minutes.

MCQ 3. An infant's weight, length, and head circumference all fall below the 10th percentile for gestational age. Which classification applies?
  • A) Large for gestational age (LGA)
  • B) Appropriate for gestational age (AGA)
  • C) Small for gestational age (SGA)
  • D) Preterm appropriate
  • E) Post-term large
Answer: C — Small for gestational age (SGA) SGA = growth parameters <10th percentile. These infants are at risk for hypothermia and hypoglycemia.

MCQ 4. Which of the following mothers is MOST likely to deliver a large-for-gestational-age (LGA) infant?
  • A) A mother with iron deficiency anaemia
  • B) A mother with uncontrolled gestational diabetes
  • C) A mother with pre-eclampsia
  • D) A mother who smokes
  • E) A mother with hypothyroidism
Answer: B — Uncontrolled gestational diabetes LGA infants (growth parameters >90th percentile) are commonly born to mothers with uncontrolled diabetes; they are at risk for neonatal hypoglycaemia.

MCQ 5. At birth, a healthy newborn's brain mass is approximately what percentage of adult brain mass?
  • A) 10%
  • B) 26%
  • C) 40%
  • D) 55%
  • E) 75%
Answer: B — 26% Brain mass is 26% of adult at birth, 55% at 1 year, and reaches near-adult proportions by end of year 2.

MCQ 6. Growth in height in girls typically ceases earlier than in boys because of:
  • A) Lower levels of growth hormone in females
  • B) Earlier epiphyseal fusion driven by oestrogen
  • C) Lower caloric intake in adolescent girls
  • D) Delayed production of IGF-1 in females
  • E) Testosterone suppression of bone growth
Answer: B — Earlier epiphyseal fusion driven by oestrogen Oestrogen causes rapid growth between ages 11–13 but leads to epiphyseal closure around ages 14–16, ending female height gain earlier than in males.

MCQ 7. The new Ballard score is used to assess:
  • A) Nutritional status of the newborn
  • B) Risk of neonatal sepsis
  • C) Gestational age of the newborn
  • D) Severity of respiratory distress
  • E) Degree of hypoxic-ischaemic encephalopathy
Answer: C — Gestational age of the newborn The Ballard score evaluates neuromuscular and physical maturity criteria to estimate gestational age.

MCQ 8. A low Apgar score of 0–3 at 5 minutes is MOST associated with which outcome?
  • A) Cerebral palsy in all affected infants
  • B) Confirmed prenatal hypoxia
  • C) Increased risk of neonatal death
  • D) Guaranteed long-term neurological deficit
  • E) Need for immediate cardiac surgery
Answer: C — Increased risk of neonatal death A score of 0–3 at 5 minutes may correlate with neonatal death but cannot independently confirm an in-utero hypoxic event or predict all neurological outcomes.

MCQ 9. Behavioural development in infancy is primarily determined by:
  • A) Nutritional status alone
  • B) Maturity of the nervous system
  • C) Maternal education level
  • D) Birth weight
  • E) Gestational age only
Answer: B — Maturity of the nervous system Behavioural growth is principally related to nervous system maturity, including myelination of CNS tracts, which is not complete until the end of the first year.

MCQ 10. Which of the following is a recognised reason an Apgar score may be falsely low?
  • A) Maternal iron supplementation
  • B) Vaginal delivery
  • C) Prematurity
  • D) Post-term birth
  • E) Breastfeeding initiation
Answer: C — Prematurity Gestational age, maternal medications, neurologic and cardiorespiratory conditions, trauma, and infection can all affect the Apgar score.

SAQs (Short Answer Questions)


SAQ 1. List the five components of the Apgar score, the criteria for each score (0, 1, 2), and state what is considered a normal score.
Model Answer:
Sign012
Heart rateAbsent<100 bpm≥100 bpm
RespirationsAbsentIrregular/slowStrong cry
Muscle toneLimpSome flexionActive motion
Reflex irritabilityNo responseGrimaceCough/sneeze/cry
ColourBlue/pale all overBlue extremities, pink bodyCompletely pink
  • Assessed at 1 and 5 minutes
  • Normal = 7–10
  • Score <7 requires repeat every 5 minutes up to 20 minutes
  • Resuscitation must not be interrupted to calculate the score
  • (Textbook of Family Medicine 9e, p. 527)

SAQ 2. Describe the classification of newborns based on growth parameters relative to gestational age, and state one complication associated with each abnormal category.
Model Answer:
  • AGA (Appropriate for Gestational Age): weight, length, and head circumference between the 10th–90th percentile — normal
  • SGA (Small for Gestational Age): parameters <10th percentile
    • Complications: temperature instability, hypoglycaemia
  • LGA (Large for Gestational Age): parameters >90th percentile
    • Most commonly born to mothers with uncontrolled diabetes
    • Complication: neonatal hypoglycaemia
All parameters must be plotted on growth charts and the Ballard score used to confirm gestational age.

SAQ 3. Describe the pattern of height growth in boys vs. girls during puberty, explaining the underlying hormonal mechanisms and their effects on the epiphyses.
Model Answer:
  • Girls: Oestrogen causes rapid height gain starting around age 11–13, but also leads to early epiphyseal fusion (ages 14–16), ending growth sooner
  • Boys: Testosterone drives growth from approximately age 13–17, with delayed epiphyseal fusion, resulting in a longer growth window and greater final adult height
  • Net result: males achieve a greater final height despite beginning their pubertal growth spurt later
  • (Guyton & Hall Medical Physiology, p. 1057)

SAQ 4. What is the significance of brain growth in the first two years of life? What clinical monitoring is implied?
Model Answer:
  • At birth, brain mass = 26% of adult mass
  • At 1 year = 55% of adult mass
  • By end of year 2 = near-adult proportions
  • Fontanelles and cranial sutures close during this period, allowing only ~20% additional growth beyond age 2
  • CNS tracts are not fully myelinated until end of year 1
  • Clinical implication: Developmental progress charts (like Figure 84.9 in Guyton) should be used to track motor, language, and social milestones and identify delays early

LAQs (Long Answer Questions)


LAQ 1. Write a comprehensive account of the assessment of the newborn infant, including the Apgar score, growth parameter classification, and gestational age estimation.
Model Answer (Outline):

1. Immediate Newborn Assessment — The Apgar Score

  • Developed to provide a rapid, standardised assessment of newborn condition
  • Scored at 1 and 5 minutes after birth (repeated at 5-min intervals up to 20 min if <7)
  • Five parameters (each scored 0–2):
    • Heart rate, Respirations, Muscle tone, Reflex irritability, Colour
  • Interpretation:
    • 7–10: Normal
    • 4–6: Moderately depressed
    • 0–3: Severely depressed (correlates with neonatal mortality risk at 5 min)
  • Limitations: Score affected by prematurity, maternal drugs, neurological/cardiorespiratory conditions, infection, ongoing resuscitation
  • Resuscitation takes priority over Apgar scoring

2. Assessment of Growth Parameters

  • Measure and plot: weight, length, head circumference on standardised growth charts
  • Classifications:
    • AGA: 10th–90th percentile
    • SGA (<10th percentile): risks include hypoglycaemia, hypothermia
    • LGA (>90th percentile): often born to diabetic mothers; risk for hypoglycaemia
  • Head circumference monitoring detects hydrocephalus or microcephaly

3. Gestational Age Assessment — New Ballard Score

  • Combines neuromuscular maturity (posture, arm/leg recoil, popliteal angle, scarf sign, heel-to-ear) and physical maturity (skin, lanugo, plantar surface, breast, eye/ear, genitalia)
  • Results categorise the infant as term, preterm, or post-term
  • Important because preterm infants require different management protocols

4. Behavioural Development Monitoring

  • Formal developmental progress charts are used to track:
    • Motor milestones (rolling, sitting, standing, walking)
    • Language milestones
    • Social/adaptive milestones
  • CNS myelination is incomplete at birth → reassessment at each well-child visit
  • Brain mass reaches 55% of adult by age 1 and near-adult proportions by age 2

5. Initial Paediatric History for a New Infant

  • Birth history (gestation, delivery mode, complications)
  • Nutritional history (breastfed vs. formula)
  • Developmental milestones achieved
  • Immunisation record
  • Environmental history (parental smoking, household hazards)

LAQ 2. Discuss the growth and behavioural development of a child from birth to 20 years, with reference to the hormonal control of growth and the factors influencing neurological maturation.
Model Answer (Outline):

1. Physical Growth — Heights and Weights

  • Boys and girls grow at parallel rates through the first decade
  • Growth is regulated by:
    • Growth hormone (GH) and IGF-1 — primary drivers throughout childhood
    • Thyroid hormones — essential for normal skeletal and brain development
    • Nutritional status — caloric and protein intake critical especially in first 2 years

2. Pubertal Growth Spurts

  • Girls (age 11–13): Oestrogen-driven rapid growth, but early epiphyseal fusion (ages 14–16) → height stops
  • Boys (age 13–17): Testosterone-driven growth spurt, later and more prolonged epiphyseal fusion → greater final height
  • Bone age (assessed by wrist X-ray) reflects epiphyseal maturity more accurately than chronological age

3. Brain and Neurological Development

  • Brain at birth = 26% adult mass; 55% at 1 year; ~adult by age 2
  • Fontanelles and skull sutures allow rapid expansion in first 2 years; then restrict to ~20% additional growth
  • CNS myelination is incomplete at birth → explains primitive reflex dominance in neonates
  • Cortical functions (vision, voluntary movement) develop progressively over the first months

4. Behavioural Milestones (First Year — Key Examples)

AgeMotorLanguageSocial
2 monthsHolds head upCooingSocial smile
4–6 monthsRolls over, sits with supportBabblingRecognises parents
9 monthsStands with support"Mama/Dada" (non-specific)Stranger anxiety
12 monthsWalks with support1–2 words (specific)Waves bye-bye

5. Factors Influencing Development

  • Biological: genetics, nutrition, chronic illness, hormonal status
  • Environmental: caregiver-infant relationship, stimulation, socioeconomic status
  • Pathological: CNS infections, lead exposure, hypothyroidism, prematurity

6. Clinical Application

  • Developmental progress charts are used at every well-child visit
  • Delays trigger further evaluation (vision, hearing, neurology referral)
  • Early intervention is most effective when abnormalities are identified in the first 2 years

Sources: Guyton & Hall Textbook of Medical Physiology; Textbook of Family Medicine 9e; Harriet Lane Handbook 23e

Note: "Topic 1" varies by curriculum. If your course specifically covers neonatology, nutrition, immunisations, or a different unit, share the exact topic title and I can generate questions precisely matched to your syllabus.

Continue with nutrition and breastfeeding and neonatology common questions

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Excellent — I now have comprehensive source material. Let me compile the full question set.

Pediatrics 1 — Nutrition, Breastfeeding & Neonatology


SECTION A: NUTRITION & BREASTFEEDING

MCQs


MCQ 1. According to WHO recommendations, exclusive breastfeeding should be continued for:
  • A) 3 months, then complementary foods introduced
  • B) 4 months, then formula supplemented
  • C) 6 months, then complementary foods introduced
  • D) 12 months exclusively
  • E) Until the infant doubles birth weight
Answer: C — 6 months Exclusive breastfeeding for 6 months is the global standard, after which complementary foods are introduced while breastfeeding continues up to 2 years or beyond.

MCQ 2. Which immunoglobulin is present in the highest concentration in colostrum and provides mucosal immunity to the newborn?
  • A) IgG
  • B) IgM
  • C) IgE
  • D) IgA (secretory)
  • E) IgD
Answer: D — Secretory IgA (sIgA) Colostrum is rich in secretory IgA, which coats the neonatal gut mucosa and provides passive immunity against pathogens. Breast milk also contains lactoferrin and lysozyme.

MCQ 3. A breastfed newborn develops jaundice on day 4 of life with total bilirubin of 14 mg/dL. The infant is feeding well and gaining weight. Serology is negative for haemolysis. The MOST likely diagnosis is:
  • A) Biliary atresia
  • B) Crigler-Najjar syndrome
  • C) Breast milk jaundice
  • D) Sepsis-associated jaundice
  • E) Haemolytic disease of the newborn
Answer: C — Breast milk jaundice Breast milk jaundice is caused by bilirubin-deconjugating enzymes in breast milk. It is unconjugated, benign, and peaks around days 5–15. The infant is clinically well.

MCQ 4. Which of the following is NOT a recognised benefit of breastfeeding for the infant?
  • A) Reduced risk of necrotising enterocolitis
  • B) Protection against respiratory infections
  • C) Reduced risk of sudden infant death syndrome (SIDS)
  • D) Increased risk of obesity in later childhood
  • E) Passive transfer of maternal antibodies
Answer: D — Increased risk of obesity Breastfeeding is actually associated with a REDUCED risk of childhood obesity. All other options are proven benefits of breastfeeding.

MCQ 5. At what age should complementary (solid) foods typically be introduced alongside breastfeeding?
  • A) 2 months
  • B) 4 months
  • C) 6 months
  • D) 9 months
  • E) 12 months
Answer: C — 6 months Before 6 months, the infant's gut is not mature enough for solids. Introduction before 4 months is associated with allergies and obesity risk.

MCQ 6. A neonate with poor maternal nutrition and exclusively breastfed after the first week of life is at highest risk for deficiency of which vitamin?
  • A) Vitamin C
  • B) Vitamin D
  • C) Vitamin A
  • D) Vitamin E
  • E) Vitamin B12 (if mother is vegan)
Answer: E — Vitamin B12 (if mother is vegan) Breast milk from a vegan mother may be severely B12-deficient. Vitamin D supplementation is also universally recommended for breastfed infants. Both are commonly tested in exams — B12 deficiency causes irreversible neurological damage.

MCQ 7. Haemorrhagic disease of the newborn (vitamin K deficiency bleeding) is prevented by:
  • A) Oral iron supplementation
  • B) Vitamin C supplementation at birth
  • C) Vitamin K given intramuscularly at birth
  • D) Folic acid supplementation
  • E) Exclusive breastfeeding
Answer: C — Vitamin K given intramuscularly at birth *Breast milk has marginal vitamin K content. IM vitamin K at birth prevents deficiency of factors II, VII, IX, and X and thus prevents bleeding. (Bradley & Daroff's Neurology, p. 1250)

MCQ 8. Which of the following is a contraindication to breastfeeding?
  • A) Maternal hepatitis B infection
  • B) Mastitis without abscess
  • C) Maternal HIV infection in a high-income country with safe formula available
  • D) Infant with cleft palate (can still breast or cup feed)
  • E) Maternal mild common cold
Answer: C — Maternal HIV in a high-income country In settings where safe formula is reliably available, HIV+ mothers are advised not to breastfeed to prevent vertical transmission. In low-resource settings, WHO recommends continued breastfeeding with antiretroviral therapy.

SAQs — Nutrition & Breastfeeding


SAQ 1. List FIVE advantages of breastfeeding for the infant and TWO advantages for the mother.
Model Answer:
For the infant:
  1. Passive immunity via secretory IgA, lactoferrin, and lysozyme
  2. Reduced risk of respiratory and gastrointestinal infections
  3. Reduced risk of necrotising enterocolitis (NEC), especially in preterm infants
  4. Reduced risk of SIDS
  5. Reduced risk of childhood obesity, type 1 diabetes, and allergies
  6. (Bonus) Promotes gut microbiome colonisation and immune system maturation
For the mother:
  1. Promotes uterine involution (oxytocin release reduces postpartum haemorrhage)
  2. Reduced risk of breast and ovarian cancer
  3. (Bonus) Lactational amenorrhoea (natural contraception), bonding

SAQ 2. Differentiate between physiological jaundice and breast milk jaundice in the neonate.
FeaturePhysiological JaundiceBreast Milk Jaundice
OnsetDay 2–3Day 4–7
PeakDay 3–5Day 5–15
ResolutionBy day 14 (term)Can persist up to 3 months
Bilirubin typeUnconjugatedUnconjugated
CauseImmature hepatic UGT; high RBC turnoverBilirubin-deconjugating enzymes in breast milk
Infant appearanceWellWell
ManagementSupportive; phototherapy if high levelsContinue breastfeeding; phototherapy if needed
Sources: Robbins Basic Pathology; Tietz Laboratory Medicine 7e

LAQ — Nutrition & Breastfeeding


LAQ 1. Discuss the composition and benefits of human breast milk, the appropriate timing of complementary feeding, and the management of breastfeeding-associated jaundice.
Outline:

1. Composition of Breast Milk

  • Colostrum (days 1–5): High in sIgA, lactoferrin, lymphocytes, protein; low volume but highly concentrated
  • Transitional milk (days 5–14): Increasing fat and lactose
  • Mature milk (after day 14):
    • Carbohydrate: lactose (primary energy source)
    • Fat: long-chain polyunsaturated fatty acids (DHA, ARA — critical for brain development)
    • Protein: whey-dominant (easier to digest than casein in formula)
    • Immunological factors: sIgA, IgG, IgM, lactoferrin, lysozyme, cytokines, macrophages
    • Hormones and growth factors (e.g., EGF, insulin-like growth factors)
    • Vitamins: adequate except Vitamin D and B12 (in vegan mothers)

2. Benefits of Breastfeeding

  • Infant: immune protection, reduced NEC, SIDS, obesity, allergy, diabetes
  • Mother: involution, cancer risk reduction, bonding, contraception
  • Economic: no cost, always available, correct temperature

3. Complementary Feeding

  • Introduced at 6 months
  • Foods should be energy-dense, soft, varied
  • Iron-rich foods are especially important as breast milk iron decreases after 6 months
  • Breastfeeding should continue alongside solids up to 2 years or beyond (WHO)

4. Breastfeeding-Associated Jaundice

  • Type 1 — Breastfeeding failure jaundice (early onset, day 2–3): Due to inadequate caloric intake/dehydration → ↑ enterohepatic circulation of bilirubin → Management: improve latch, feeding frequency, supplement if needed
  • Type 2 — Breast milk jaundice (late onset, day 4–15+): Due to bilirubin-deconjugating glucuronidase enzymes in breast milk → unconjugated hyperbilirubinaemia → Management: continue breastfeeding; phototherapy if bilirubin crosses treatment threshold; exchange transfusion rarely needed
  • Both are benign in healthy term infants; persistent or conjugated jaundice requires urgent investigation (biliary atresia, metabolic disease)

SECTION B: NEONATOLOGY

MCQs


MCQ 9. A preterm infant born at 28 weeks develops progressive respiratory distress within hours of birth. Chest X-ray shows a "ground-glass" appearance with air bronchograms. The underlying defect is:
  • A) Meconium aspiration
  • B) Pulmonary surfactant deficiency
  • C) Diaphragmatic hernia
  • D) Congenital pneumonia
  • E) Tracheo-oesophageal fistula
Answer: B — Pulmonary surfactant deficiency Neonatal Respiratory Distress Syndrome (RDS)/Hyaline Membrane Disease is caused by surfactant deficiency in preterm lungs, leading to alveolar collapse. Classic CXR: ground-glass opacity with air bronchograms.

MCQ 10. Which of the following is the MOST serious complication of untreated severe neonatal unconjugated hyperbilirubinaemia?
  • A) Hepatic cirrhosis
  • B) Cholestatic liver disease
  • C) Kernicterus (bilirubin encephalopathy)
  • D) Haemolytic anaemia
  • E) Coagulopathy
Answer: C — Kernicterus *Unconjugated bilirubin crosses the blood–brain barrier (especially immature BBB of preterm/low-birth-weight infants) and deposits in the basal ganglia and brainstem nuclei, causing irreversible brain damage. (Tietz Laboratory Medicine 7e, p. 867)

MCQ 11. A neonate with kernicterus presents with which clinical triad in the chronic phase?
  • A) Hypotonia, hepatomegaly, petechiae
  • B) Choreoathetoid cerebral palsy, high-frequency deafness, upward gaze palsy
  • C) Spastic diplegia, mental retardation, seizures
  • D) Macrocephaly, bulging fontanelle, sunset sign
  • E) Opisthotonos, fever, hypoglycaemia
Answer: B — Choreoathetoid cerebral palsy, high-frequency deafness, upward gaze palsy *The classic chronic kernicterus triad. Acute features include lethargy, high-pitched cry, opisthotonos, and seizures. Approximately 50% of affected infants die acutely. (Bradley & Daroff's Neurology, p. 1250)

MCQ 12. Phototherapy works in neonatal jaundice by:
  • A) Increasing hepatic glucuronosyltransferase activity
  • B) Converting unconjugated bilirubin to a water-soluble isomer excreted in urine
  • C) Oxidising conjugated bilirubin in bile
  • D) Stimulating albumin binding of bilirubin
  • E) Reducing enterohepatic recirculation of bilirubin
Answer: B — Converting unconjugated bilirubin to a water-soluble photoisomer *Blue-light phototherapy (wavelength ~460 nm) converts bilirubin IXα to lumirubin and other soluble photoisomers that bypass hepatic conjugation and are excreted in bile and urine. (Robbins Basic Pathology; Medical Physiology)

MCQ 13. Which of the following is the MOST common complication seen in preterm neonates?
  • A) Biliary atresia
  • B) Congenital heart disease
  • C) Neonatal respiratory distress syndrome (hyaline membrane disease)
  • D) Pyloric stenosis
  • E) Hirschsprung disease
Answer: C — Neonatal RDS (hyaline membrane disease) *RDS is the single most common serious complication of prematurity, along with sepsis, necrotising enterocolitis, and intraventricular haemorrhage. (Robbins & Kumar Pathologic Basis of Disease)

MCQ 14. A newborn boy has bleeding from the umbilical stump and circumcision site on day 3 of life. Coagulation screen shows prolonged PT and APTT with normal platelet count. The MOST likely cause is:
  • A) Haemophilia A
  • B) Disseminated intravascular coagulation
  • C) Thrombocytopenia
  • D) Haemorrhagic disease of the newborn (Vitamin K deficiency)
  • E) Von Willebrand disease
Answer: D — Haemorrhagic disease of the newborn *Transitory deficiency of vitamin K-dependent clotting factors (II, VII, IX, X) causes bleeding in the first postnatal week. Poor placental transfer of Vitamin K and low breast milk content are the main causes. IM Vitamin K at birth is preventive. (Bradley & Daroff's Neurology, p. 1250)

MCQ 15. Neonatal polycythaemia is defined as a central haematocrit of:
  • A) ≥50%
  • B) ≥55%
  • C) ≥60%
  • D) ≥65%
  • E) ≥70%
Answer: D — ≥65% *Neonatal polycythaemia is defined as a central haematocrit ≥65%. Associated complications include hypoglycaemia, hypocalcaemia, and thrombocytopenia. Treatment includes partial exchange transfusion, hydration, and correction of metabolic disorders. (Bradley & Daroff's Neurology)

SAQs — Neonatology


SAQ 3. Describe the pathophysiology, clinical features, and management of neonatal respiratory distress syndrome (RDS/hyaline membrane disease).
Model Answer:
Pathophysiology:
  • Caused by deficiency of pulmonary surfactant (dipalmitoylphosphatidylcholine) in immature lungs, typically <34 weeks gestation
  • Without surfactant, alveolar surface tension is high → alveolar collapse on expiration → ↓ lung compliance
  • Hypoxia → capillary damage → fibrin-rich exudate lines alveoli ("hyaline membranes")
Clinical Features:
  • Onset within hours of birth in preterm neonate
  • Tachypnoea, nasal flaring, intercostal/subcostal retractions, expiratory grunting
  • Cyanosis, progressive hypoxia
  • CXR: bilateral ground-glass opacity with air bronchograms, reduced lung volume
Management:
  • Prevention: Antenatal corticosteroids (betamethasone/dexamethasone) to mother if preterm delivery anticipated — accelerates fetal lung maturity
  • Treatment:
    • Supplemental oxygen / mechanical ventilation / CPAP
    • Exogenous surfactant (intratracheal instillation) — cornerstone of treatment
    • Supportive: warmth, glucose, fluids, antibiotics if sepsis suspected

SAQ 4. Outline the causes, clinical features, and management of neonatal jaundice, distinguishing physiological from pathological causes.
Model Answer:
Physiological Jaundice:
  • Onset day 2–3, peaks day 3–5, resolves by day 14 in term infants
  • Caused by: high neonatal RBC turnover (fetal Hb replacement), immature hepatic UGT enzyme, increased enterohepatic bilirubin recirculation
  • Management: observation; phototherapy if bilirubin nears treatment threshold
Pathological Jaundice (suspect if):
  • Appears within 24 hours of birth → think haemolytic disease (Rh or ABO incompatibility)
  • Conjugated bilirubin elevated → always abnormal → investigate (biliary atresia, neonatal hepatitis, sepsis, metabolic)
  • Persists >2 weeks (term) or >3 weeks (preterm) without explanation
Causes of unconjugated hyperbilirubinaemia:
  • Haemolytic: Rh/ABO incompatibility, G6PD deficiency, hereditary spherocytosis
  • Non-haemolytic: physiological, breast milk, Crigler-Najjar, Gilbert's
Management:
  • Phototherapy: first-line for elevated unconjugated bilirubin; blue light (460 nm) converts to soluble photoisomers
  • Exchange transfusion: for rapidly rising bilirubin, imminent or actual kernicterus risk, failure of phototherapy
  • Treat underlying cause (antibiotics for sepsis, etc.)

SAQ 5. What is kernicterus? Describe its acute presentation, chronic sequelae, and preventive measures.
Model Answer:
  • Definition: Bilirubin-induced neurological dysfunction caused by deposition of unconjugated bilirubin in the basal ganglia and brainstem nuclei; most dangerous in low-birth-weight and preterm infants
  • Risk threshold: Bilirubin >340 µmol/L (20 mg/dL) in term infants
Acute Phase:
  • Lethargy, poor feeding, hypotonia
  • High-pitched cry, fever
  • Opisthotonos (backward arching of trunk)
  • Seizures → ~50% mortality
Chronic Sequelae (survivors):
  • Choreoathetoid cerebral palsy
  • High-frequency sensorineural deafness
  • Upward gaze palsy
  • Mental retardation, learning deficits
Prevention:
  • Universal bilirubin screening before discharge
  • Phototherapy when bilirubin approaches treatment threshold (AAP nomograms)
  • Exchange transfusion for dangerous levels
  • (Tietz Laboratory Medicine 7e; Bradley & Daroff's Neurology, p. 1250)

LAQ — Neonatology


LAQ 2. Write a comprehensive account of the common problems of the preterm neonate, their pathophysiology, clinical features, and management.
Outline:

1. Definition

  • Preterm: birth before 37 completed weeks of gestation
  • Very preterm: <32 weeks; Extremely preterm: <28 weeks

2. Neonatal Respiratory Distress Syndrome (RDS)

  • Cause: Surfactant deficiency → alveolar collapse
  • Features: Grunting, tachypnoea, retractions, ground-glass CXR within hours
  • Management: Antenatal steroids, CPAP/ventilation, exogenous surfactant

3. Intraventricular Haemorrhage (IVH)

  • Bleeding from the fragile germinal matrix into the ventricles
  • Graded I–IV; Grade III–IV carries high risk of hydrocephalus and neurodevelopmental disability
  • Managed supportively; severe cases may need ventriculoperitoneal shunt

4. Necrotising Enterocolitis (NEC)

  • Ischaemic/inflammatory necrosis of intestinal wall, usually ileum and colon
  • Presents: abdominal distension, bloody stools, feeding intolerance, systemic sepsis
  • CXR/AXR: pneumatosis intestinalis (air in bowel wall), portal venous gas
  • Management: nil by mouth, IV antibiotics, surgical resection if perforation

5. Neonatal Sepsis

  • Early onset (<72 hours): GBS, E. coli (maternal flora)
  • Late onset (>72 hours): Staphylococcus aureus, coagulase-negative Staph, Gram-negatives
  • Features: temperature instability, lethargy, poor feeding, apnoea, hypoglycaemia
  • Management: blood culture, lumbar puncture, empirical IV antibiotics (ampicillin + gentamicin)

6. Hypoglycaemia

  • Definition: blood glucose <2.6 mmol/L (<47 mg/dL) in a neonate
  • Risk groups: SGA, preterm, LGA (diabetic mothers), hypothermic infants
  • Features: jitteriness, apnoea, lethargy, seizures
  • Management: early feeding, IV dextrose if symptomatic or glucose persistently low

7. Jaundice

  • Physiological more pronounced and prolonged in preterm (immature liver)
  • Lower phototherapy thresholds used in preterms
  • Monitor for kernicterus risk

8. Haemorrhagic Disease of the Newborn

  • Vitamin K deficiency → prolonged PT/APTT, normal platelets
  • Bleeding from umbilicus, GI tract, intracranially
  • Prevention: IM Vitamin K 1 mg at birth

9. Temperature Regulation

  • Preterm infants lack subcutaneous fat and brown adipose tissue → hypothermia rapidly
  • Management: incubator/warmer, kangaroo mother care

10. General Supportive Care

  • IV fluids, parenteral nutrition initially
  • Minimal handling, developmental positioning
  • Family-centred care and kangaroo care when stable

Sources: Robbins & Kumar Pathologic Basis of Disease (10e); Robbins Basic Pathology; Bradley & Daroff's Neurology in Clinical Practice; Tietz Textbook of Laboratory Medicine 7e; Textbook of Family Medicine 9e; Harriet Lane Handbook 23e

This completes the three-part Pediatrics 1 set. If your course has additional topics (e.g. immunisations/vaccines, paediatric infections, growth charts in practice, or fluid management in children), just say the word and I'll generate questions for those as well.
This is a shared conversation. Sign in to Orris to start your own chat.